The original PROOF-HD trial of pridopidine was negative, but a new analysis showed it has clinically meaningful effects in ...

Responses to dupilumab (Dupixent) treatment were consistent across racial and ethnic groups in children with atopic ...

Taking 500 mg cephalexin twice daily is as effective as taking it four times daily for treating urinary tract infections in ...

A scoping review highlights the dermatologic conditions affecting US migrants and identifies key factors influencing their ...

The new clinical guide reveals gender-specific cardiovascular risks and prevention strategies for women across all life ...

The US Food and Drug Administration (FDA) has approved nivolumab (Opdivo, Bristol Myers Squibb) with ipilimumab (Yervoy, ...

The first prospective trial of a palatable elemental diet shows symptom improvement, microbiome changes, and full adherence in patients with SIBO and IMO.

The US Food and Drug Administration (FDA) has approved bevacizumab-nwgd (Jobevne, Biocon Biologics Ltd), a biosimilar to bevacizumab (Avastin, Genentech), for intravenous use across multiple cancer ...

The new name and endorsement at the World Diabetes Congress are seen as long overdue recognition that will spur more research ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease ( COPD ), are the fifth-leading ...

An analysis of exhaled breath, using an electronic nose, demonstrates potential for accurately detecting lung cancer in ...